Phenylbutazone Production Cost Reports

The report provides a detailed analysis essential for establishing a Phenylbutazone production plant. It encompasses all critical aspects necessary for Phenylbutazone production, including the cost of Phenylbutazone production, Phenylbutazone plant cost, Phenylbutazone production costs, and the overall Phenylbutazone production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Phenylbutazone production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Phenylbutazone is a nonsteroidal anti-inflammatory drug (NSAID) with major applications in the pharmaceutical and veterinary industries. It is widely used as an anti-inflammatory drug for the treatment and management of pains associated with musculoskeletal disorders, sprains, tendinitis, arthritis, and laminitis in horses. It is also utilized as a drug for the treatment of soft tissue injury(lameness) and other bone and joint problems in animals. It also finds its limited application as a pain-relieving drug for the treatment of ankylosing spondylitis, backache, and gout in humans.

The market for Phenylbutazone is primarily led by its demand as an analgesic drug for relieving pain and treating tissue injuries in animals. Its utilization as a medication for pain management in musculoskeletal disorders, laminitis, sprains, and tendinitis largely promotes its demand in the veterinary industry. Its limited usage as a drug for treating ankylosing spondylitis and gouty arthritis in humans also fuels its demand in the medical and pharmaceutical industries.

The use of Phenylbutazone is restricted to animals due to severe side effects in humans, including the risk of aplastic anemia. Therefore, its production and distribution are closely monitored by regulatory bodies, and its compliance with Good Manufacturing Practices (GMP) significantly influences industrial Phenylbutazone procurement. Variations in demand from the veterinary medicine industry driven by disease prevalence in animal populations or changes in veterinary drug choices further impact its pricing and procurement strategies.

Raw Material for Phenylbutazone Production

According to the Phenylbutazone production plant project report, the major raw materials for Phenylbutazone production include Diethyl-n-butylmalonate and 1,2-Diphenylhydrazine.

Production Process of Phenylbutazone

The extensive Phenylbutazone production cost report consists of the following industrial production process:

• Production from Diethyl-n-butylmalonate: This method of production involves the synthesis of Phenylbutazone by using diethyl-n-butylmalonate and 1,2-diphenylhydrazine as the starting materials. The process starts with the chemical reaction of diethyl-n-butylmalonate and 1,2-diphenylhydrazine in the presence of sodium ethoxide at the temperature of 150 °C, followed by acidification, which leads to the formation of phenylbutazone as the final product.

Phenylbutazone is a chemical compound that belongs to the family of pyrazolidines. The molecular formula of the compound is C19H20N2O2, and its molar mass is around 308.4 g/mol. The compound is slightly soluble in water with a solubility of 47.5 mg/L at 30°C. Moreover, it is readily soluble in methanol. It appears as a tasteless, odorless, and white to off-white crystalline powder. It is unstable in the presence of strong oxidizing agents. Its solution has a pH of around 8.2. The melting point of the compound is 105 °C. It decomposes upon heating while releasing toxic fumes of nitrogen oxides. The compound has a pKa value of 4.5. It is recommended to store the compound at room temperature and in a container away from moisture.